Middle East Pharmaceutical Industries Co. (4016)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

21 September 08:28 AM Avalon Pharma extends SAR 104m facility agreement with Banque Saudi Fransi

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) extended a Sharia-compliant banking facility agreement with Banque Saudi Fransi totaling SAR 104 million. The credit line is specifically designated to fund the …

Company News

20 August 08:36 AM Avalon Pharma extends SAR 50m credit facility deal with Alinma Bank

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) renewed its Sharia-compliant banking facility agreement with Alinma Bank on 19 August at a value of SAR 50 million. The credit facility is scheduled for a duration of …

Banking and Finance

18 August 11:19 AM Avalon Pharma finalizes exclusive licensing deal with China’s Bio-Thera Solutions

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) penned a strategic licensing and marketing agreement with China-based Bio-Thera Solutions. Under the terms of the 15-year renewable contract, Avalon Pharma obtained …

Company News

11 August 02:54 PM Avalon Pharma declares SAR 28m cash dividends for H1-26

Riyadh - Mubasher: The board of Middle East Pharmaceutical Industries Company (Avalon Pharma)  approved a cash dividend distribution totaling SAR 28 million for the first half (H1) of 2026. The distribution will target 35 million eligible shares, …

Cash Dividends

9 August 02:04 PM Avalon Pharma’s net profits climb 26% in H1-26

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) announced a net profit of SAR 55.70 million for the first half (H1) of 2026, marking a 25.99% increase from SAR 44.21 million during the same period in 2025. The …

Financial Results

16 April 07:02 PM Avalon Pharma appoints new leadership team

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next four years. The ordinary general meeting (OGM), which was held on 9 April 2026, also resolved to …

Company News

6 April 06:07 PM CMA greenlights Avalon Pharma’s capital hike

Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to increase its capital to SAR 350 million from SAR 200 million. The company will issue three bonus shares …

Management Decisions

4 February 11:16 AM Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with Bio-Thera Solutions to register Pembrolizumab in Saudi Arabia and MENA markets Under the agreement, …

Companies Investments

13 April 2025 09:30 AM Avalon Pharma unveils SAR 25m cash dividends for H2-24

Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million for the second half (H2) of 2024, according to a bourse filing. The Saudi group will disburse SAR 1.25 …

Board of Directors

31 July 2024 11:58 AM Avalon Pharma’s board approves dividends for H1-24

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million, equivalent to 7.50% of the capital, for the first half (H1) of 2024. Avalon Pharma will pay out a dividend of …

Cash Dividends

9 July 2024 11:49 AM Avalon Pharma obtains SAR 70m from Emirates NBD

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) secured a Sharia facility amounting to SAR 70 million from Emirates NBD on 8 July 2024. The Saudi company obtained the loan for one year to finance its operations, …

Banking and Finance